Autonomous Therapeutics (Autonomous) is an emerging biotech company founded in New York City in 2017 by scientists from Harvard Medical School and the University of California, San Francisco (UCSF).

Our team is developing first-in-class, broad-spectrum antivirals that evolve along with mutating viral infections—to provide lifelong, resistance-proof disease control.